Recent Funding
Investors
University of Cambridge Enterprise

University of Cambridge Enterprise portfolio

University of Cambridge Enterprise has 6 portfolio companies on record at Recent Funding.

Website: enterprise.cam.ac.uk.

Type: Government fund.

Portfolio on Recent Funding: 6.

Deals, last 12 months: 0.

Capital in their rounds: $115.64M.

Latest deal: Echion Technologies · Jun 13, 2024.

About this page

It is a government fund based in Cambridge, GB, founded in 2005. Its most recent investment on record is Echion Technologies's $37M Series B+ round in June 2024, alongside Volta Energy Technologies, CBMM, Green Spark Ventures and 1 other. By category, its portfolio leans toward Health and bio (3) and Climate and energy (2). It has co-invested with Cambridge Innovation Capital, CBMM and Volta Energy Technologies, most often Cambridge Innovation Capital (2 rounds).

About University of Cambridge Enterprise

Firm type: Government fund.

Headquarters: Cambridge, GB.

Founded: 2005.

Stages: Pre-Seed, Seed, Series A, Late Stage.

Sectors: AgTech, Biotech, Cleantech, Data & Infrastructure, Deep Tech, Energy, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.

Portfolio companies: 6.

Exits: 0.

Rounds led: 0.

What University of Cambridge Enterprise invests in

Health and bio · 3 · 50%
Climate and energy · 2 · 33%
Manufacturing and industrial · 2 · 33%
Stablecoins · 1 · 17%
Fintech · 1 · 17%

University of Cambridge Enterprise recent investments

Company	Round	Date	Alongside
EEchion Technologies	Series B+ · $37M	Jun 13, 2024	Volta Energy Technologies (lead), CBMM, Green Spark Ventures +1
TT-Therapeutics	Series A · $59M	Nov 15, 2023	Digitalis Ventures (lead), Cambridge Innovation Capital (lead), Sanofi Ventures +2
NNyobolt	Series A · $10M	Feb 25, 2021	IQ Capital (lead), ARVO VENTURE CAPITAL
RRiverlane	Seed · $4.14M	Jun 12, 2019	Cambridge Innovation Capital (lead), Amadeus Capital Partners (lead)
CCambridge Epigenetix	Series A · $5.5M	Oct 29, 2014	New Science Ventures (lead), Syncona Partners LLP

How University of Cambridge Enterprise invests

Stage	Deals	Capital in rounds
Series A	3 60%	$74.5M
Series B+	1 20%	$37M
Seed	1 20%	$4.14M

Year	Deals	Capital in rounds
2014	1 20%	$5.5M
2019	1 20%	$4.14M
2021	1 20%	$10M
2023	1 20%	$59M
2024	1 20%	$37M

University of Cambridge Enterprise portfolio companies

EEchion Technologies$37MSeries B+ · Jun 2024
TT-Therapeutics$59MSeries A · Nov 2023
NNyobolt$10MSeries A · Feb 2021
RRiverlane$4.14MSeed · Jun 2019
CCambridge Epigenetix$5.5MSeries A · Oct 2014
CCardiaTec Biosciencesbacker

Company	Round with University of Cambridge Enterprise	Total raised	Latest raise
EEchion Technologies Climate and energy	Jun 13, 2024 Series B+ · $37M	$53M	Jun 13, 2024 Series B+
TT-Therapeutics Health and bio	Nov 15, 2023 Series A · $59M	$150M	Nov 13, 2025 Series A
NNyobolt Climate and energy	Feb 25, 2021 Series A · $10M	$129M	May 6, 2026 Series B+
RRiverlane	Jun 12, 2019 Seed · $4.14M	$97.8M	Aug 6, 2024 round
CCambridge Epigenetix Health and bio	Oct 29, 2014 Series A · $5.5M	$93.5M	Nov 2, 2021 Series B+
CCardiaTec Biosciences Stablecoins	backer	undisclosed	—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 5 rounds on Recent Funding that name University of Cambridge Enterprise. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists University of Cambridge Enterprise, which is a subset of its real portfolio. API: /api/v1/investors/university-of-cambridge-enterprise (get a free API key). More: the most active VC firms and new venture capital funds.